about
In vitro and in vivo modulation of cholinergic muscarinic receptors in rat lymphocytes and brain by cholinergic agentsImmunotoxicology: role of inflammation in chemical-induced hepatotoxicityDecreased resistance to Listeria Monocytogenes in mice following vanadate exposure: effects upon the function of macrophagesModulation of t-cell ontogeny by transplacental benzo(a)pyreneNitric oxide induces chemotaxis of neutrophil-like HL-60 cells and translocation of cofilin to plasma membranesImiquimod applied topically: a novel immune response modifier and new class of drugEffect of a garlic derivative (alliin) on peripheral blood cell immune responsesAndrostenediol stimulates myelopoiesis and enhances resistance to infection in gamma-irradiated miceHuman immunodeficiency virus-1 recombinant gp120 induces changes in protein kinase C isozymes--a preliminary reportAnti-leprosy drugs inhibit the complement-mediated solubilization of pre-formed immune complexes in vitroComparative study of transfer factor and acyclovir in the treatment of herpes zosterAugmentation of protective immune responses against Sendai virus infection by fungal polysaccharide schizophyllanModification of spleen cell subsets by chronic cocaine administration and murine retrovirus infection in normal and protein-malnourished miceExperimental model of autoimmune hemolytic anemia induced in mice with levodopa by intraperitoneal injection or oral feedingMethyl inosine monophosphate: a potential immunotherapeutic for early human immunodeficiency virus (HIV) infectionMechanism of immunosuppressive effect of alprazolam: alprazolam suppresses T-cell proliferation by selectively inhibiting the production of IL2 but not acquisition of IL2 receptorLow molecular weight human T-cell response immunopotentiator: alpha-2'-deoxy-3-deazaguanosineActivation of T-cells by bryostatins: induction of the IL-2 receptor gene transcription and down-modulation of surface receptorsImmunomodulatory effect of a newly synthesized compound, TOK-8801 (N-(2-phenylethyl)-3,6,6-trimethyl-5,6-dihydroimidazo [2,1-b]thiazole-2-carboxamide) on antibody production in vivo and delayed-type hypersensitivity in miceLymphocyte mitogenesis and CD4 modulation induced by different phorbol esters: comparative studiesCI-922--a novel, potent antiallergic compound--I. Inhibition of mediator release in vitroCI-922--a novel, potent antiallergic compound--II. Activity in animal models of allergyReconstitution of cytolytic alloreactivity with N-[4-[(4-fluorophenyl) sulfonyl]phenyl]acetamide (CL 259,763) in animals immunocompromised by cyclophosphamideFK506 inhibition of histamine release and cytokine production by mast cells and basophilsIncreased T cell cytotoxicity by Betathine-induced upregulation of TNFalphaInhibition of endotoxin-induced TNF-alpha production in macrophages by 5Z-7-oxo-zeaenol and other fungal resorcylic acid lactonesInhibitory effect of natural and environmental estrogens on thymic hormone production in thymus epithelial cell culture(9-[4-acetyl-3-hydroxy-2-n-propylphenoxy) methyl]-3-(1H-tetrazol-5-yl)-4H-pyrido [1,2-a] pyrimidin-4-one), AS-35, inhibits leukotriene synthesisMechanism of the impaired T-cell proliferation in adult rats exposed to alcohol in uteroLevamisole, the story and the lessonsReview Article Imiquimod applied topically: a novel immune response modifier and new class of drugAnti-arthritic activity of boswellic acids in bovine serum albumin (BSA)-induced arthritisThe specific type IV phosphodiesterase inhibitor rolipram combined with adenosine reduces tumor necrosis factor-alpha-primed neutrophil oxidative activity.Immunostimulation by bacterial components: I. Activation Of macrophages and enhancement of genetic immunization by the lipopeptide P3CSK4.Thymosin-alpha1 stimulates maturation of CD34+ stem cells into CD3+4+ cells in an in vitro thymic epithelia organ coculture model.Erratic behavior of nitric oxide within the immune system: illustrative review of conflicting data and their immunopharmacological aspects.Inhibition of leukotriene B4-induced increase in intracellular calcium ion level of human peripheral blood polymorphonuclear leukocytes by Y-24180, an antagonist of platelet-activating factor receptor.Differential effect of dipyridamole upon thymidine incorporation and expression of surface activation antigens by in vitro stimulated lymphocytes.Neutropenia as a complication of intravenous immunoglobulin (IVIG) therapy in children with immune thrombocytopenic purpura: common and non-alarming.Experimental studies of the hematologic and immune system toxicity of nucleoside derivatives used against HIV infection.
P1433
Q23917153-E35D75B6-1A4D-4BF3-93E4-65B89A72D546Q23918266-49AF733A-B8EB-48E4-B35B-496F031E64D3Q23918504-9FF5F008-B016-4475-ADC4-579D7FBB5782Q23924167-FEE58D52-1F04-4690-8EC8-205EEF067980Q28138475-2BC34621-8FE4-4D8E-9244-9339E795F775Q28140002-632A48DF-2EF6-4DB2-B039-C89C650E2425Q28145201-8A8CAE71-1CBD-41D1-BC75-B59C78554395Q28145308-362918A7-0C6C-4352-B879-CA2348085E20Q28254882-902959DB-6C06-40D7-825F-F9701FB824BBQ28278432-645E9F95-823B-4928-B140-12A230064829Q28290545-87492E38-272A-4D2E-9794-55B099F9E598Q28297709-70F7F09E-3739-4BE8-B222-703334DF8CC6Q28317566-129EE606-A1DB-4089-BA45-8F234FA0C4BCQ28317569-3AD14E05-E783-4218-BBE4-2A55638DED3BQ28318708-AB1FD8D0-E14A-4926-AA2E-3A9F9419CB68Q28320720-5CE2CC94-FCFD-4698-ABD4-9EF288E701E8Q28330148-7E87CF2B-2A51-400D-A5B3-2B1C670EBCB9Q28331359-DF55A3D1-836E-4A10-8D03-D27ACEF99CB0Q28331363-A3AFB703-E9C4-415C-9766-7F2796A6D69AQ28332851-B2D1AF9C-3A8B-4650-A371-A6E53306AF56Q28338023-D3F42990-0E8F-4CDE-8AFB-252BE4E96877Q28338027-11F7F2F3-C8F1-471D-9508-E9F3D23313BDQ28342084-4420D2E6-F398-4D2C-877F-42746A024F82Q28370871-F1E92D09-5C7D-49D2-A7E6-C451BE4CCDC8Q28370874-29390B6F-5B87-49B8-9309-1FAD77C6AC3DQ28377914-670CA5E2-2383-4730-9D38-ADC0A9177A69Q28377918-02C3C79D-2FDE-4694-966F-8C5AA2677EBEQ28377948-E32F5877-258F-4848-B14D-BBCDFF001CABQ28565665-C30939CD-202C-43F4-A6D3-BC5DD21CB676Q29039809-113C1735-2D32-4D8B-BB01-6D421B8D8796Q29396548-9D815D5D-E318-4466-AB0F-D756262F387AQ29999322-5BEB24E5-7F81-446E-BCA4-1FCAE4F2276CQ30468705-4A2F2D65-C6F2-4FBE-8DA9-1E8D464C2FD7Q30642273-A1E65EA0-042E-4DC7-B11C-756B54119FC6Q30737100-DAC6EBF1-7802-46DF-96F9-726E22B20531Q32012648-D3B65CA4-D265-4E86-8232-8BFAEFF9A572Q32052661-797A0EA4-B298-47B8-B4C8-0D89DD219E4EQ33192415-E4BC03D9-BAC9-40F6-BA74-056F8BA19A20Q33329469-88F0460E-D311-4846-8FB9-4ED15259AAB0Q33371157-C402B579-32A0-4ABE-BC25-BCA29DE7DD58
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Elsevier
@nl
wissenschaftliche Fachzeitschrift
@de
name
International Journal of Immunopharmacology
@ast
International Journal of Immunopharmacology
@en
International Journal of Immunopharmacology
@es
International Journal of Immunopharmacology
@it
International Journal of Immunopharmacology
@nl
type
label
International Journal of Immunopharmacology
@ast
International Journal of Immunopharmacology
@en
International Journal of Immunopharmacology
@es
International Journal of Immunopharmacology
@it
International Journal of Immunopharmacology
@nl
prefLabel
International Journal of Immunopharmacology
@ast
International Journal of Immunopharmacology
@en
International Journal of Immunopharmacology
@es
International Journal of Immunopharmacology
@it
International Journal of Immunopharmacology
@nl